No products in the cart.
CEREBROLYSIN 5 AMP 5 ML
515.00 EGP
| * Cerebrolysin 5ml – 5 ampoules of 5 ml. Solution for injection / concentrate for solution for infusion. | ||
| * Administration: Intramuscular (I.M.) or I.V. (intravenous) use. | ||
| * Active ingredient: 1ml contains: 215.2mg of Cerebrolysin concentrate in aqueous solution. Excipients: Sodium hydroxide, water for injection. | ||
| * For the modern, safe and effective treatment of disturbed cerebral functions. | ||
| * Indications: | ||
| – Disturbances of concentration && memory. | ||
| – Degenerative dementias, including Alzheimer’s disease. | ||
| – Vascular dementias, e.g. multi-infarct dementia. | ||
| – Mixed forms of dementia (degenerative && vascular contribution). | ||
| – Sequels of stroke (ischaemic && haemorrhagic). | ||
| – Posttraumatic or postoperative complaints e.g., following cerebral contusion, concussion, or neurosurgical operation. | ||
| * Contra-indications: | ||
| – Status epilepticus or grand mal convulsions; an increase in the seizure frequency may be seen in these cases. | ||
| – Severe impairment of renal function. | ||
| * Warnings and precautionary measures: | ||
| & Patients with severe renal impairment must be excluded from a Cerebrolysin therapy. Animal experimental data did | ||
| & not show any evidence of teratogenic effects. There is no clinical experience with Cerebrolysin in pregnant women. | ||
| & Therefore, unless the potential benefits outweigh any potential risk, Cerebrolysin should not be administered during | ||
| & pregnancy and the lactation period. | ||
| * Interactions: Concomitant administration of Cerebrolysin with antidepressive drugs or MAO inhibitors can lead to cumulative effects. | ||
| & In these cases a dose reduction of the antidepressive drug is advisable. | ||
| * Dosage: Cerebrolysin is available in 1mL, 5mL and 10mL ampoules and in vials of 30mL and 50mL. Up to 5mL per | ||
| & intramuscular administration, for administrations over 5mL an intravenous injection or infusion is advised. | ||
| & Cerebrolysin can also be given diluted in a standard IV solution (eg. physiological saline solution, Ringer’s | ||
| & solution, glucose 5%, dextran 40) infused slowly over approximately 20 to 60 minutes. Once daily applications | ||
| & of Cerebrolysin for a minimum of 10 to 20 days are recommended. This constitutes a course of therapy. | ||
| & In mild cases 1-5mL, in severe cases 10-30mL should be applied. The length of the therapy and the individual | ||
| & doses depends on the age of the patient as well as on the severity of the disease. Usually a treatment period | ||
| & of 3 to 4 weeks is recommended. Therapy courses can be repeated several times in accordance with the | ||
| & clinical picture of the patient until no further improvement can be observed. Therapy-free intervals should be | ||
| & maintained between courses. In severe cases it is advisable not to interrupt treatment abruptly but to continue | ||
| & with one injection every other day for a period of 4 weeks. | ||
& From the above mentioned clinical trials the following daily dosage guidelines for adults can be d
Q & AThere are no questions yet Ask a question Your question will be answered by a store representative or other customers. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Thank you for the question! Your question has been received and will be answered soon. Please do not submit the same question again. Error  An error occurred when saving your question. Please report it to the website administrator. Additional information: Add an answer This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Thank you for the answer! Your answer has been received and will be published soon. Please do not submit the same answer again. Error An error occurred when saving your answer. Please report it to the website administrator. Additional information: Related products الأدوية المضادة لتجلط الدم
170.00 EGP  الأدوية المضادة لتجلط الدم
406.00 EGP  الأدوية المضادة لتجلط الدم
236.00 EGP  الأدوية المضادة لتجلط الدم
406.00 EGP |